WO1987001135A1 - A method of detecting infectious aids virus - Google Patents
A method of detecting infectious aids virus Download PDFInfo
- Publication number
- WO1987001135A1 WO1987001135A1 PCT/DK1986/000093 DK8600093W WO8701135A1 WO 1987001135 A1 WO1987001135 A1 WO 1987001135A1 DK 8600093 W DK8600093 W DK 8600093W WO 8701135 A1 WO8701135 A1 WO 8701135A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- substrate
- serum
- virus
- fluid sample
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
Definitions
- the present invention concerns a method of detecting infectious AIDS virus in human tissue fluids, such as blood or plasma.
- the disease AIDS (acquired immunodeficiency syndrome) has only been known for a few years, but has developed almost explosively since 1981. At the end of 1984, more than 10,000 new cases were registered in the United States, but it is expected that another 10,000 cases will occur in 1985.
- AIDS is caused by a virus called LAV (lymphadenopathy- associated virus) or HTLV-III (human T-cell lympho- tropic virus type III).
- LAV lymphadenopathy-associated virus
- HTLV-III human T-cell lympho- tropic virus type III
- This virus specifically in ⁇ fects T-4 lymphocytes, which play a central part in the control of the immunity system.
- the disease is particularly dangerous for immune deficiency patients because the patient is susceptiple to a large number of diseases to which he is normally immune. Examples are pulmonary diseases which develop mortally in such patients in a short time, and Kaposi's sarcoma which was previously an extremely rare disease, but which now attacks AIDS patients at a rate of more than 30_. It is also known that many AIDS patients suffer or have suffered from hepatitis.
- the object of the present invention is to solve the above-mentioned problem by providing a method of de ⁇ tecting infectious AIDS in tissue fluid samples.
- Another object of the invention it to detect whether infectious AIDS is present in injection preparations It is known from Nature, vol. 316, 1985, p. 69-74 and 262-265, that virus produced from HTLV-III genome is infectious and exerts a significant cytopathic effect in vitro on T4 positive cells. Thus, human cells in suspension with T4 markers have been cultivated in a substrate containing HTLV-III virus. A cytopathic effect could be detected on the cells after cultiva ⁇ tion for some days.
- the present invention is based on the idea that a ono- layer culture of human cells with T4 markers may be used for specifically identifying infectious AIDS virus in tissue fluids and other fluid samples. It has sur ⁇ prisingly been found that this provides a very safe identification and a rational and simplified procedure.
- the method which is of the type stated in the intro ⁇ ductory portion of claim 1, is thus characterized by the subject-matter in the characterizing portion of the claim.
- the invention also concerns the use of human cells selected from a cell line of high affinity to LAV/HTLV- III virus.
- Such cells may be obtained by treating and cultivating lymphocytes or leukemia cells, but useful cells may also be obtained from cerebral, lung, mucosa, hepatic or renal tissue.
- the monolayer culture is propagated in a serum-contain- ing substrate for developing active cells, and then the active cells are incubated with a serum-free substrate containing the fluid sample, followed by the cultiva ⁇ tion of the cell culture with a substrate having a low content of serum.
- a cytopathic effect on the culti ⁇ vated cells may be detected after a certain period of time. The detection may take place microscopically, but any other detection method may also be used. Ex- amples of this are specific colour reactions or
- flurorescent antibody test a) direct method b) indirect method 6) reverse transcriptase activity measurement.
- LAV/HTLV-III virus types closely related to LAV/HTLV-III cause the same or a similar cytopathic effect on human cells with T4 markers.
- vira of the visna type such as Maedi-visna virus which attacks sheep, see Nature New Biology, vol. 237, May 24, 1972, p. 114-115.
- LAV/HTLV- III virus is now classified as belonging to the sub ⁇ family lenti-virus, which also includes Maedi-visna virus, the RNA structure and the morphological proper ⁇ ties being closely related.
- a sample with a known content of AIDS virus may be used as a positive control in the present method of detecting AIDS virus.
- a virus having correspond ⁇ ing properties may be used, such a Maedi-visna. This obviates the risk of infection of the laboratory staff with AIDS virus from the reagents and aids used.
- the selected cell line with T4 markers is inoculated into a multi-dish cultivation bowl with 24 holes, the same number of cells being inoculated into each hole so that 2/3 of confluent are obtained in 2 days. After a suitable growth (2/3 confluent), each hole is flushed 3 times with a growth medium containing peni ⁇ cillin and streptomycin, but without any content of seru .
- the culture is incubated with the 3rd portion of growth medium which is added for 10 minutes at 37°C, and then the growth medium is removed. Following this, the holes are treated individually in the following manner:
- 1st row of holes (4 holes for positive control) are provided with 1 ml of growth medium without serum con ⁇ tent, but with 2-fold dilutions of LAV/HTLV-III virus.
- test rows 0.5 ml of sample material and 0.5 ml of growth medium without serum are added to 4 . test holes in each row.
- the cultivation bowls are incubated at 37°C for 4 hours. Then all liquid is sucked out of all holes. Then, 3 ml of antibiotics (penicillin and streptomycin) and 2_ fetal calf serum are added to ' each hole. The cultivation bowls are then incubated at 37°C for up to 30 days.
- antibiotics penicillin and streptomycin
- 2_ fetal calf serum are added to ' each hole.
- CPE cytopathic effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK379385A DK152517B (da) | 1985-08-21 | 1985-08-21 | Fremgangsmaade til paavisning af infektioes aids-virus |
DK3793/85 | 1985-08-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1987001135A1 true WO1987001135A1 (en) | 1987-02-26 |
Family
ID=8126828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1986/000093 WO1987001135A1 (en) | 1985-08-21 | 1986-08-20 | A method of detecting infectious aids virus |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0233264A1 (da) |
AU (1) | AU6332286A (da) |
DK (1) | DK152517B (da) |
WO (1) | WO1987001135A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU609447B2 (en) * | 1987-02-19 | 1991-05-02 | Nissin Shokuhin Kabushiki Kaisha | Methods and materials for hiv detection and therapy |
-
1985
- 1985-08-21 DK DK379385A patent/DK152517B/da not_active Application Discontinuation
-
1986
- 1986-08-20 EP EP19860905238 patent/EP0233264A1/en not_active Ceased
- 1986-08-20 AU AU63322/86A patent/AU6332286A/en not_active Abandoned
- 1986-08-20 WO PCT/DK1986/000093 patent/WO1987001135A1/en not_active Application Discontinuation
Non-Patent Citations (4)
Title |
---|
MEDLINE (NLM Database) Accession number 85258784 Jpn. J. Cancer. (GANN) 1985, June 76 (6): 432-5 (Harada S., Yamamoto N) "Quantitative Analysis of AIDS-Related Virus Carrying Cells by Plaque-forming Assy Using an HTLV-I-positive MT-4 Cell Line". * |
Nature Vol 312, p 763-67 published 20/27 December 1984 (DALGLEISH A.G. et al) "The CD4 (T4) Antigen in an Essential Component of the Receptor for the AIDS Retrovirus". * |
Science Vol 224, p 497-500 published 4 May 1984 (POPOVIC M. et al) "Detection, Isolation and Continuous Production of Cytopathic Retroviruses (HTLV-III) from patients with AIDS and Pre-AIDS". * |
Science Vol 229, p 563-66 published 9 August 1985 (HARADS S. et al) "Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT4 and Application in Plaque Assay". * |
Also Published As
Publication number | Publication date |
---|---|
DK379385D0 (da) | 1985-08-21 |
AU6332286A (en) | 1987-03-10 |
DK152517B (da) | 1988-03-07 |
DK379385A (da) | 1987-03-23 |
EP0233264A1 (en) | 1987-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Klement et al. | Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture | |
Lieber et al. | S‐tropic murine type‐C viruses: Frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens | |
Igarashi et al. | Evolution and properties of Aedes albopictus cell cultures persistently infected with Sindbis virus | |
Klement et al. | Differences in susceptibility of human cells to mouse sarcoma virus | |
Burge et al. | Temperature-sensitive mutants of Sindbis virus: biochemical correlates of complementation | |
Friesen et al. | Some physicochemical and immunological properties of an avian leucosis virus (RIF) | |
de Souza et al. | Comparison of isolation in cell culture with conventional and modified mouse antibody production tests for detection of murine viruses | |
Halstead et al. | Susceptibility to rubella among adolescents and adults in Hawaii | |
Nyberg et al. | Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes | |
Ju et al. | Isolation of a heterogeneous population of temperature-sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines. | |
Phillpotts et al. | A search for persistent virus infection in Crohn's disease. | |
Oie et al. | Host-range properties of murine xenotropic and ecotropic type-C viruses | |
WO1987001135A1 (en) | A method of detecting infectious aids virus | |
Cool et al. | No detectable XMRV in subjects with chronic fatigue syndrome from Quebec | |
Schumacher et al. | Markers for measles virus: II. Tissue culture properties | |
McCormick et al. | Replication of mengovirus in HeLa cells preinfected with nonreplicating poliovirus | |
Fattal et al. | Enterovirus types in Israel sewage | |
Hsiung | The impact of cell culture sensitivity on rapid viral diagnosis: a historical perspective. | |
Poiley | Methods for the detection of adventitious viruses in cell cultures used in the production of biotechnology products | |
LANGLOIS et al. | Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay | |
Nir | Some characteristics of Israel turkey virus | |
Duncan | Human thyroid tissue culture in diagnostic virology | |
Hampil et al. | Method for testing virus stocks for viral contaminants | |
US6740519B1 (en) | Immortalized, homozygous stat1-deficient mammalian cell lines and their uses | |
RU1440029C (ru) | Штамм диплоидных клеток кожи и мышц эмбоиона человека, используемый в качестве тест-системы для определения антивирусной активности интерферонов человека и размножения вирусов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU DK FI JP NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1986905238 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1986905238 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1986905238 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1986905238 Country of ref document: EP |